Tutti
← Back to Squawk list
US Air Force C-17 moves 500,000 Covid test swabs from Italy to USA for distribution
“On March 17, [Air Mobility Command] transported a shipment of 13 pallets of Covid-19 testing supplies aboard a C-17 Globemaster III from Aviano Air Base, Italy, to the Memphis Air National Guard Base where the 164th Airlift Wing C-17 is assigned,” says the USAF. “Air Mobility Command is postured to support additional requests to deliver Covid-19 testing supplies in the coming weeks.” Upon arrival in Memphis the swabs were loaded onto FedEx aircraft for distribution throughout the USA, the… (www.flightglobal.com) Altro...Sort type: [Top] [Newest]
The swabs are produced in northern Italy. The majority of swabs are manufactured in this one place. With Covid 19 hitting northern Italy hard, every day activities came to a screeching halt. That is why the Air Force was given the job of getting as many swabs as possible and transporting them back. My husband is a microbiologist and that is what he told me.
It's funny that we Italians (and European) have been treated as plague victims by your president: all flights closed shut down without notice (with the usual insults associated magnifying the superiority of US industry and response to the pandemia) but then a C17 is sent to... Italy, to collect swabs...
just to clarify, I believe is totally ok to exchange medical equipment with any other country, also for free if required. What I really don't like that this is ok only when a country is in need.
Bear in mind 50K of swabs is merely a pallet of them. Hardly moved my world.
500K, not 50K. Just to say...
ARE these swabs produced in Italy???
Or are these the same swabs that China gave to Italy and the Italian government said to STOP USING then Immediately, because they had a 68 percent false Negative rate. Only 22% of the tests correctly identified patients already known to have previously tested positive?
Or are these the same swabs that China gave to Italy and the Italian government said to STOP USING then Immediately, because they had a 68 percent false Negative rate. Only 22% of the tests correctly identified patients already known to have previously tested positive?